Advertisement
Are compounding pharmacies safer now?

Are compounding pharmacies safer now?

By Lisa Schencker  |  December 17, 2014

The indictment of 14 people Wednesday—including two pharmacists on charges of second-degree murder—was the latest in a string of actions taken in response to a deadly 2012 fungal meningitis outbreak linked to a Massachusetts compounder.

Renewed U.S.-Cuba relations could impact both nations' healthcare

By Adam Rubenfire  |  December 17, 2014

U.S. and Cuban healthcare providers could benefit from renewed U.S.-Cuban relations announced Wednesday by President Barack Obama, industry experts said. U.S. devicemakers, in particular, could soon have access to a new market hungry for its products.

PCORI wades into effectiveness of controversial hepatitis drugs

PCORI wades into effectiveness of controversial hepatitis drugs

By Jaimy Lee  |  December 11, 2014

A not-for-profit organization created and funded by the healthcare reform law plans to spend up to $50 million on comparative effectiveness research for hepatitis C treatments just as the government is set to approve the third drug in a new breed of treatment regimens.

Antibiotic-resistant bug battle wins bipartisan support in Congress

By Jaimy Lee  |  December 11, 2014

A bill surfaced in the final days of the current Congress with bipartisan support to ease regulatory requirements to get drugs that treat antibiotic-resistant bacteria approved, and it is expected to also be considered by the new Congress in January.

Antitrust suit accuses Sovaldi maker Gilead of price-gouging

By Lisa Schencker  |  December 10, 2014

Gilead Sciences' eye-popping $1,000-a-pill cost for its hepatitis C drug Sovaldi is illegal price-gouging with the potential to bankrupt parts of the healthcare industry, according to a lawsuit filed in federal court Tuesday.

Burwell moves to encourage Ebola vaccine development, use

By Steven Ross Johnson  |  December 09, 2014

The drugmakers of three potential vaccines in development against the Ebola virus will be immune from legal liability related to their production, testing or distribution, federal officials announced Tuesday.

Merck committed to Cubist after patent losses

By Associated Press  |  December 09, 2014

Merck remains committed to its $8.4 billion acquisition of Cubist Pharmaceuticals even though a federal court invalidated most of the patents protecting the company's top-selling antibiotic just hours after that deal was announced Monday.

Two Calif. biomed advocacy groups to merge

By Adam Rubenfire  |  December 08, 2014

The San Diego-based California Healthcare Institute and the San Francisco-based Bay Area Bioscience Association will merge next year to become the California Biomedical Innovation Alliance. The new organization, expected to be formed by the end of the first quarter of 2015, will represent the...

Pregnant women to get better info from drug labels

By Associated Press  |  December 03, 2014

Pregnant and worried about your medication? The Food and Drug Administration is revamping those confusing labels on prescription drugs to make it easier to understand which are safe to use.

Advertisement
Modern Healthcare Daily

The top stories in healthcare business every day

The Modern Healthcare Daily News App provides you with registration-free access to the top trending healthcare business news. It's the only news you need each day.

Sponsored by